Navigation Links
Cethromycin Achieves All Endpoints in Second Pivotal Phase III Trial for Treatment of Pneumonia
Date:11/15/2007

all and live webcast at 9:00 a.m. ET today to discuss the results from Trial CL-05 and the third quarter 2007 financial results. On the call, Advanced Life Sciences management will be joined by Donald E. Low, M.D., a recognized authority in microbiology and infectious diseases.

The conference call will be webcast simultaneously over the Internet. Please visit the Investor Relations section of Advanced Life Sciences' corporate website http://www.advancedlifesciences.com. Alternatively, callers may participate in the conference call by dialing 866-510-0704 (domestic) or 617-597-5362 (international). The passcode for the conference call is 57071751.

A telephone replay of the call will also be available for 48 hours. Callers may access the telephone replay by dialing (domestic) 888-286-8010 or 617-801-6888 (international), passcode 51192916.

About Community Acquired Pneumonia (CAP)

CAP is the sixth most common cause of death in the United States. CAP and other respiratory tract infections are caused by pathogens such as Streptococcus pneumoniae and Haemophilus influenzae. CAP affects 5.6 million patients in the United States each year, with 10 million physician visits and 2 million hospitalizations occurring annually.

Macrolides and penicillins are currently the front-line treatments for respiratory tract infections such as CAP. As macrolide and penicillin resistance grows and has the potential to cause more clinical failures, there is a need for new antibiotics with unique mechanisms of action that can overcome this emerging resistance.

About Cethromycin

Cethromycin has shown higher in vitro potency and a broader range of activity than macrolides against Gram-positive bacteria associated with respiratory tract infections, and, again in in vitro tests, it appears to be effective against penicillin- and macrolide-resistant bacteria. Cethromycin has a mechanism of act
'/>"/>

SOURCE Advanced Life Sciences Holdings, Inc.
Copyright©2007 PR Newswire.
All rights reserved

1

GOOD

Page: 1 2 3 4 5 6 7 8 9 10 11

Related medicine technology :

1. Advanced Life Sciences Collaborates with U.S. Government to Study Cethromycin as Treatment for Anthrax and Other High-Priority Biodefense Agents
2. Advanced Life Sciences to Present Data on Selected Cethromycin Therapeutic Studies at the 47th Interscience Conference on Antimicrobial Agents and Chemotherapy
3. Further Data on Safety and Efficacy of Cethromycin Presented at 47th Interscience Conference on Antimicrobial Agents and Chemotherapy
4. Further Data on Safety and Efficacy of Cethromycin Presented at 47th Interscience Conference on Antimicrobial Agents and Chemotherapy
5. Large Blinded Clinical Study Achieves High Accuracy for the Diagnosis of Melanoma Using In Vivo Confocal Microscopy
6. Avastin Achieves Impressive Rate of Curative Surgery in Patients with Advanced Colorectal Cancer
7. Phase III Clinical Trial in Newly Diagnosed Multiple Myeloma Stopped Early Due to Highly Significant Efficacy Advantage of VELCADE(R) (Bortezomib) for Injection Based Therapy Across All Endpoints
8. A Phase II, Randomized, Double Blind, Placebo-Controlled Dose-Escalating Study, Meets the Clinical Endpoints of MTR106 Tablets During the Treatment of Acute Migraine Attacks Without Aura in Females
9. Spherix Reports Second Quarter Earnings
10. Tapestry Reports Second Quarter 2007 Results
11. Callisto Reports on Second-Quarter 2007 Milestones
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/4/2008)...- Southern Research Institute,today announced that...ted,the organization to participate in the newly-f...Network (MLPCN). The MLPCN -- a collaborative,rese... Program which is,designed to benefit human health... and validate future targets for drug discovery., ...
(Date:9/4/2008)...umab to be Presented, PRINCETON, N.J., Sept. 4 /P...DX ) announced today that nine clinical abstracts ...ibody, in melanoma are scheduled to be,the subject...pean Society,for Medical Oncology (ESMO) being hel...following abstracts will include updated one-year ...
(Date:9/4/2008)...h Two Abstracts Accepted for Presentation, and...IDGEWATER, N.J., Sept. 4 /- Aegerion ...company focused on the treatment of,cardiovascular...tment of,Peter L. Garrambone, Jr. to the Company,s...ncludes more than 50 pharmaceutical,transactions e...
(Date:9/3/2008)...tCall/ -- Simcere,Pharmaceutical Group (NYSE: SCR... generic pharmaceuticals and manufacturer of the p...wn as Endostar) in China,announced the interim re...quest of the SFDA, Simcere initiated a Phase IV cl...erapeutic efficacy of Endu, a modified,version of ...
Breaking Medicine Technology:Southern Research Institute Wins $14.7 Million NIH Award to Participate in Molecular Libraries Probe Production Center Network 2Southern Research Institute Wins $14.7 Million NIH Award to Participate in Molecular Libraries Probe Production Center Network 3Southern Research Institute Wins $14.7 Million NIH Award to Participate in Molecular Libraries Probe Production Center Network 4Medarex Announces Presentations at the 33rd Congress of the European Society for Medical Oncology 2Medarex Announces Presentations at the 33rd Congress of the European Society for Medical Oncology 3Aegerion Pharmaceuticals, Inc. adds Peter Garrambone to Board of Directors, Secures Additional Capital for Clinical Trials 2Simcere Pharmaceutical Group Announces Interim Results of Endu Phase IV Clinical Study 2Simcere Pharmaceutical Group Announces Interim Results of Endu Phase IV Clinical Study 3Workshop Helps Parents Kids Talk About Sex 23817 1Workshop Helps Parents Kids Talk About Sex 23817 2Non parental care of infants tied to unfavorable feeding practices 23813 1Non parental care of infants tied to unfavorable feeding practices 23813 2Non parental care of infants tied to unfavorable feeding practices 23813 3I Play Clean 28TM 29 and Old Spice Kick Off Campaign Challenging High School Students to Pledge Against Steroid Use 23809 1I Play Clean 28TM 29 and Old Spice Kick Off Campaign Challenging High School Students to Pledge Against Steroid Use 23809 2I Play Clean 28TM 29 and Old Spice Kick Off Campaign Challenging High School Students to Pledge Against Steroid Use 23809 3I Play Clean 28TM 29 and Old Spice Kick Off Campaign Challenging High School Students to Pledge Against Steroid Use 23809 4I Play Clean 28TM 29 and Old Spice Kick Off Campaign Challenging High School Students to Pledge Against Steroid Use 23809 5Chindex International Inc Announces CDC Contract Signing 23805 1Chindex International Inc Announces CDC Contract Signing 23805 2Chindex International Inc Announces CDC Contract Signing 23805 3Chindex International Inc Announces CDC Contract Signing 23805 4
...ter damage caused by,flooding over the weekend, FD...pcoming Antiviral Drugs Advisory Committee,meeting... for,maraviroc 300 milligram tablets. Originally s...aluation and Research Advisory Committee,Conferenc... the,meeting has been relocated to , Crown Plaza H...
...-- Sirion Therapeutics,Inc., an ophthalmic-focuse...it has received orphan drug designation from the F...al therapy,ganciclovir, for the treatment of acut...keted by Laboratoires Thea in Europe under,the bra...o,Virgan(R) for the United States from Laboratoire...
Other Medicine Technology:FDA Announces Change of Location Notice for Upcoming Advisory,Committee Meeting 2Sirion Therapeutics Receives Orphan Drug Designation for Ophthalmic,Drug to Treat Viral Eye Infection 2
(Date:9/5/2008)...G, Pa., Sept. 5 /PRNewswire-USNewswire/ -- Childre...r access to comprehensive,services to protect thei...n,in grants that were announced today by the Depar...vices for children and families, the department,be...ren,s Services Planning,initiative, ICSP, in 2004....
(Date:9/5/2008)..., Md., Sept. 5 /PRNewswire-USNewswire/ -- The Heal...day announced $39 million in grants to,increase an...centers., "These grants continue President Bush,s...whose services now reach more economically,vulnera...r before," HRSA,Administrator Elizabeth M. Duke sa...
(Date:9/5/2008)...ontrolled, but you need to know what triggers them...thDay News) -- If you are one of the 36 million Am...is nowhere in the United States that is free from ... shows. , Allergies don,t only happen in the sp...ell. In the fall, the most challenging cities to l...
(Date:9/5/2008)...N, Sept. 5 /PRNewswire-USNewswire/ -- Speaker Nanc...upport of the aims of the "Stand,Up to Cancer" tel...re is not a person in our country who has not seen...s 565,000 Americans annually, and each,year there ... must work,together to make eradicating the scourg...
Breaking Medicine News(10 mins):Health News:Pennsylvania Counties Receive Grants to Improve Services for Children 2Health News:HRSA Announces $39 Million in Grants to Expand, Improve Health Center Services 2Health News:No Place Safe From Allergies 2
Plump Infants Getting Obese Later In Life In More Cases
...t Johns Hopkins University claims that the drug Vi...mance// in men could also reduce the effect of hor...usly thought, drugs like Viagra can in fact alter ...y when the heart is stimulated by hormones,' said ...
...osely watching the ‘Avian Flu’ that is spreading t...rmed a task force to tackle this emergency. The ta...vedi and includes secretaries of health, environme...istries. The inter-ministerial task force is to fo...
...t depression may not be the only factor-probing ad...rs might therefore need to watch out for other men... World Health Organization re-examined the occurre... in 894 cases of completed suicides among young pe...
Other Medicine News:Health News:Viagra Halves Effect Of Hormonal Stress On Heart 2Health News:Multi targeted approach required for suicide prevention in adolescents 2
Features and Benefits: 1-12channel pipette This CLS number is a new product number, created to easily match Cornings product number. If showing no availability yet, please order under the old Sigma-A
...ell plates in mind, Pipetman Ultra Multichannel is...tions: PCR* sequencing, immunology assays, series ...mond Tips from Gilson's patented Rocky Rack system...e productivity.,* PCR process is covered by US pat...
...ion, ergonomics, and value!, Comfortable feel and...andle , Finer control while pipetting with smooth,...ction with long, lever tip ejector , Completely au...ion without the need for recalibration , Easy-to-r...
Finnpipette Focus multichannel pipettes speed up repeat dispensing of reagents into microplates, with super blow-out for 0.1-10 l volumes. The improved ergonomic design of Finnpipette Focus multichan
Medicine Products: